Genomic tests help doctors treat COVID-19 and long COVID
AMPEL’s CovGENE blood test predicts COVID19 severity and holds promise for long COVID
New test shows whether someone infected with COVID will develop a bad case
Charlottesville Based Companies Technology Predicts Severity of COVID-19 Illness in Patients and Identifies Treatments
Les Sinclair talks with Dr. Amrie Grammer about AMPEL BioSolutions, a Charlottesville Virginia company that has reengineered the gene-based technology they developed for lupus to COVID19.
A local Charlottesville company has developed a new approach to predicting the severity of the Coronavirus. Kathryn Young at CBS brings you the story.